gearwarehouseuk.com
No products in the cart.
Return To Shopgearwarehouseuk.com
No products in the cart.
Return To ShopCelkeran 2 mg, produced by Celon Labs, is an oral medication primarily indicated for the treatment of specific hematological conditions, particularly in managing chronic lymphocytic leukemia (CLL). CLL is a type of cancer that affects the blood and bone marrow, leading to the accumulation of abnormal lymphocytes. The active ingredient in Celkeran is chlorambucil, an alkylating agent classified under chemotherapy drugs. Chlorambucil works by interfering with the DNA of cancerous cells, thereby inhibiting their growth and replication.
Celkeran belongs to a group of medications that alter the behavior of immune system cells to target cancerous processes more effectively. Its chemical formula combines to form a compound that targets rapidly dividing cells, making it particularly useful in cancer treatment protocols. The drug’s formulation also ensures improved bioavailability, allowing for efficient absorption within the gastrointestinal tract.
The mechanism of action of Celkeran is centered on its ability to alkylate DNA. Upon entering the bloodstream, chlorambucil travels to areas where cancerous cells are proliferating. The drug attaches to the DNA strands of these cells, forming cross-links that prevent them from replicating properly. This disrupts the cancer cell cycle, leading to cell death and halting the advancement of the disease.
Moreover, Celkeran’s selective targeting of malignant lymphocytes helps maintain the overall health of normal, non-cancerous cells. This selective action is crucial in reducing the unwanted side effects often associated with other chemotherapy agents. In addition, chlorambucil’s relatively mild profile allows healthcare providers to implement it as a long-term treatment option while carefully monitoring the patient’s response and adjusting dosages as needed.
Despite its therapeutic benefits, Celkeran 2 mg can lead to several side effects, most related to its effects on rapidly dividing cells. Common side effects include nausea, vomiting, fatigue, and bone marrow suppression, which can result in neutropenia and increased risk of infections. Patients may also experience changes in liver enzyme levels and gastrointestinal disturbances.
To manage and reduce these side effects, patients are often advised to maintain a balanced diet rich in nutrients and to stay hydrated throughout their treatment. Regular blood tests can help monitor hematological parameters, allowing for timely intervention if abnormalities arise. Preemptively discussing any pre-existing conditions or medications with a healthcare provider is essential. They may suggest altering the dosage, switching to an alternative therapy, or implementing additional supportive treatments to minimize discomfort.
Purchasing Celkeran 2 mg in Great Britain requires an understanding of regulations governing prescription medications. It is crucial to acquire the drug through certified pharmacies or licensed healthcare providers. Trusted online pharmacies may offer Celkeran for purchase, but it is essential to ensure that they are legitimate and adhere to standard pharmaceutical practices.
Genuine sellers typically display credentials, display registration with regulatory bodies, and provide clear contact information. It is advisable to avoid unverified sources, as they may sell counterfeit products that can jeopardize health. When purchasing online, ensure that the website uses secure payment methods and offers a money-back guarantee or customer support for queries or issues related to your order.
Users of Celkeran 2 mg often report a positive experience when it comes to managing their condition effectively. Many find that the drug shows a significant response in controlling disease progression and improving their quality of life. While side effects are a common concern, a majority of patients feel that the benefits outweigh the risks, particularly when under the supervision of a knowledgeable healthcare provider.
Overall, Celkeran’s role in cancer treatment, especially for chronic lymphocytic leukemia, highlights its importance in the pharmaceutical landscape. With proper management and adherence to medical advice, patients can optimize their treatment outcomes, leading to favorable results in terms of wellbeing and disease management. As with any medication, consulting with healthcare professionals for personalized treatment plans remains imperative for a successful therapeutic experience.
| Active substance | Chlorambucil |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low |
| Lab Test | Monitoring of blood counts and liver function tests are recommended |
| Strength | 2mg |
| Also known as | Leukeran |
| Blood pressure | No significant effect |
| Trade name | Leukeran |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 4-[bis(2-chloroethyl)amino]phenylbutyric acid |
| Formula | C14H19Cl2NO2 |
| Substance class | Alkylating agent |
| Main action | Antineoplastic |
| Half-life | 1.5 hours |
| Dosage (medical) | Typically, the starting dose is 0.1 to 0.2 mg/kg/day for adults, adjusted based on response and tolerance |
| Dosage (sports) | Not applicable |
| Effects | Interferes with DNA replication and RNA transcription, ultimately leading to cell death |
| Side effects | Bone marrow suppression, nausea, vomiting, immunosuppression, infertility, secondary malignancies |
| Use in sports | None |
| Manufacturer | Celon Laboratories Pvt. Ltd. |
| Packing | 30 tabs/bottle |
€18.00
Reviews
There are no reviews yet.